Pharmaceutical Exporter from India to Yemen.
Yemen runs one of the world's largest humanitarian operations, and its pharmaceutical supply reflects that: a large share of the market is funded and procured by UN agencies and donors rather than ordinary commercial demand, and WHO-GMP with WHO prequalification is the credential that opens those channels. M Care Exports supplies into Yemen's donor-funded tenders and its licensed importers with Indian WHO-GMP medicines, honest about a conflict-affected market split between authorities in Sana'a and Aden, where access, payment, and continuity matter as much as price. India is already one of Yemen's leading medicine sources, and we treat the country as a serious, difficult market rather than a quick sale.
SBDMA, a split regulatory map, and a market that runs on donor procurement
Yemen's medicines regulator is the Supreme Board of Drug and Medical Appliances (SBDMA), historically based in Sana'a, responsible for product registration, importer licensing, and quality control. Since the conflict that escalated in 2014 and 2015, governance has split: authorities aligned with the internationally recognised government operate from Aden in the south, while the de facto authorities in Sana'a administer the north. In practice that means parallel registration, licensing, and customs touchpoints, and a supplier has to know which authority and which port govern a given consignment. We work through the Yemeni importer or the procuring agency that holds the correct local registration for the destination.
The second defining feature is that Yemen's pharmaceutical demand is heavily donor-funded. WHO, UNICEF, the World Bank through IDA-financed health projects, the Global Fund, and GAVI procure or fund a large part of the essential-medicines and vaccine supply, much of it tendered internationally through UN procurement. For those channels the decisive credential is WHO prequalification (WHO-PQ) alongside WHO-GMP, because UN agencies buy prequalified products by preference. Our honest position is that the strongest Indian lane into Yemen runs through WHO-GMP and, where the product carries it, WHO-PQ status, into donor and agency procurement and to importers serving both.
Registration with SBDMA follows the familiar pattern: a CTD-style dossier with the Certificate of Pharmaceutical Product, GMP certificate, stability data, and labelling, submitted through a licensed local agent or importer. The conflict has lengthened and complicated timelines, and the split authorities mean a registration valid in one zone is not automatically recognised in the other. We are candid that Yemen registration is slower and less predictable than a stable market, and we plan dossiers and stock around that reality rather than promising fixed lead times.
On compliance, M Care holds WHO-GMP and works with Indian partners whose sites are WHO-prequalified for specific essential molecules and vaccines; we are not US-FDA registered. For a UN procurement officer, an NGO supply lead, or a Yemeni importer, the WHO-GMP and WHO-PQ evidence is exactly what underwrites a tender bid or an import licence in a market this scrutinised.
Call & WhatsApp the Mumbai desk: +91 70156 05768 · [email protected] · Mon–Sat 09:30–18:30 IST
How we supply Yemen's donor-funded and importer channels
WHO-PQ for UN tenders
Supplying prequalified essential medicines and vaccines into UNICEF, WHO, and Global Fund-funded procurement, where WHO prequalification is the gating credential rather than a nice-to-have.
Essential-medicines focus
Catalogue built around the WHO Essential Medicines List: anti-infectives, maternal and child health, and the NCD basics that donor programmes and hospitals actually order.
Donor and NGO channel
Working with the international agencies and NGOs that fund and run a large part of Yemen's health supply, with documentation built for their procurement and audit standards.
Licensed-importer support
Backing Yemeni importers who hold SBDMA registration and the correct zone licence, with the CPP, GMP, and stability evidence their dossiers and customs clearance need.
Cold-chain into a hard environment
Validated cold-chain for vaccines and temperature-sensitive lines into a market with constrained power and infrastructure, with passive and active shippers chosen for the route.
Honest risk handling
We are explicit about the split authorities, UNVIM clearance, payment and forex constraints, and security, and we structure terms conservatively rather than pretending Yemen is a normal market.
Routing medicines through Aden, Hodeidah, and UNVIM clearance
Sea freight into government-controlled areas routes mainly through the Port of Aden, the principal functioning commercial seaport in the south, while the Red Sea port of Hodeidah is the major gateway for the north. Inbound cargo to Hodeidah and Saleef is cleared through the UN Verification and Inspection Mechanism (UNVIM), established in 2016 to inspect and clear commercial shipments to Yemeni ports outside government control. Which port a consignment uses follows the destination zone and the holding importer's licence, and we confirm that before a shipment sails.
Air freight runs through Aden and, subject to access, Sana'a, used for vaccines, cold-chain, and urgent essential lines. Cold-chain handling is planned conservatively given power and infrastructure constraints, with validated passive shippers and gel-pack or dry-ice configurations matched to transit time rather than assuming reliable cold storage on arrival.
Documentation discipline matters more here, not less. Complete CPP, GMP, stability, and SBDMA registration references, plus the UNVIM paperwork where Hodeidah is the port of entry, are staged before departure, because clearance delays in a conflict-affected market are costly and sometimes unrecoverable. Payment is structured conservatively, typically through the procuring agency, an irrevocable LC, or advance terms with established importers, given Yemeni banking and forex constraints. We treat continuity of supply, not just a single shipment, as the real deliverable.
What Yemen actually buys: essential medicines and the WHO-PQ line
The bulk of Yemen's funded demand is essential medicines. Anti-infectives, including antimalarials and treatments tied to recurring cholera and other outbreak responses, antibiotics, and oral rehydration and nutrition lines sit at the centre of donor procurement. These are exactly the WHO Essential Medicines List categories where Indian WHO-GMP supply is strongest.
Maternal, newborn, and child health is the second large block: vaccines, oxytocics, paediatric formulations, and micronutrients procured largely through UNICEF and WHO programmes. Where a product carries WHO prequalification, it moves into these tenders far more readily, which is why we lead with prequalified lines where our partners hold that status.
Non-communicable disease basics, insulin and cardiovascular and respiratory essentials, are a growing third category as the health system tries to maintain chronic care through the crisis. By contrast, high-margin specialty and lifestyle products are a small and unreliable part of this market. M Care builds a Yemen portfolio around essential, donor-funded, and importer-ordered lines rather than premium catalogue items that do not match how the country actually buys.
An international NGO running primary-health and outbreak-response programmes in Yemen approached us to second-source a block of essential anti-infectives and oral rehydration lines after a previous supplier slipped on lead times. The brief was demanding in the way Yemen always is: WHO-GMP sources, WHO-prequalified products where the molecule had a prequalified option, full CPP and stability documentation for the destination zone's authority, and a realistic plan for clearance through the correct port. We mapped the order against prequalified lines, confirmed the holding importer's registration and zone licence, staged documentation including the UNVIM set for the Red Sea routing, and shipped in two tranches to keep continuity rather than risking a single large consignment. Cold-chain items moved with validated passive shippers sized to the transit. Because the credentials and paperwork matched the procurement standard, clearance held and the programme kept its stock cover. The NGO has since added a maternal-health tranche on the same terms.
A leading Indian source for a market where credentials and continuity decide everything
India is already one of Yemen's leading sources of medicines, and for good reason: the funded demand is essential generics and prequalified products, exactly what Indian WHO-GMP industry makes at scale and price. So the question a UN procurement officer or a Yemeni importer is really asking is not whether Indian supply fits, but which Indian supplier understands a donor-driven, conflict-split market well enough to deliver against its credentials and its clearance reality. That is the supplier M Care intends to be here.
We are honest about the market, because Yemen punishes optimism. Authority is split between Sana'a and Aden, Hodeidah cargo clears through UNVIM, banking and forex are constrained, and registration is slower and less certain than anywhere stable. Within that, the durable lane is real: WHO-GMP and WHO-PQ essential medicines and vaccines, supplied into donor and agency procurement and to licensed importers, with documentation and cold-chain built for scrutiny and continuity treated as the deliverable. That is precisely where a disciplined Indian exporter belongs.
Procurement, regulatory, and access questions Yemeni buyers and agencies ask
Who regulates pharmaceutical imports into Yemen?
The Supreme Board of Drug and Medical Appliances (SBDMA) is Yemen's drug regulator, responsible for product registration, importer licensing, and quality control, historically based in Sana'a. Since the conflict escalated in 2014 and 2015, governance has split between the internationally recognised government operating from Aden and the de facto authorities in Sana'a, which in practice means parallel registration, licensing, and customs touchpoints. A registration valid in one zone is not automatically recognised in the other. M Care works through the licensed Yemeni importer or procuring agency that holds the correct registration for the destination zone.
Why does WHO prequalification matter so much for Yemen?
Because a large share of Yemen's pharmaceutical demand is funded and procured by international donors, including WHO, UNICEF, the World Bank through IDA-financed health projects, the Global Fund, and GAVI, and UN agency procurement buys WHO-prequalified products by preference. WHO-GMP is the baseline, and WHO prequalification (WHO-PQ) is what moves an essential medicine or vaccine into those tenders readily. M Care leads with prequalified lines where our manufacturing partners hold that status, alongside WHO-GMP evidence for the rest.
Can M Care sell directly into Yemen, or only through importers and agencies?
In practice, supply runs through a licensed Yemeni importer holding SBDMA registration and the correct zone licence, or through the international agency or NGO procuring for a programme. M Care supplies and documents to those parties and does not bypass local licensing. This is the compliant route and, in a conflict-affected market, also the safest for continuity and payment.
What does SBDMA registration require, and how long does it take?
A CTD-style dossier with the Certificate of Pharmaceutical Product, GMP certificate, stability data, and labelling, submitted through a licensed local agent or importer. The conflict has lengthened and complicated timelines, and the split authorities mean a dossier may need handling for the specific destination zone. We are candid that Yemen registration is slower and less predictable than a stable market, and we plan dossiers and stock buffers around that rather than promising fixed dates.
How does cargo clear, and what is UNVIM?
Sea freight into the south routes through the Port of Aden, while the Red Sea port of Hodeidah serves the north, where inbound commercial cargo is cleared through the UN Verification and Inspection Mechanism (UNVIM), established in 2016 to inspect shipments to ports outside government control. Air freight uses Aden and, subject to access, Sana'a. Which port and process apply depends on the destination zone and the importer's licence, and we confirm and stage the documentation, including the UNVIM set where relevant, before a shipment sails.
How is payment handled given Yemen's banking constraints?
Conservatively. Payment is typically through the procuring agency or NGO, an irrevocable letter of credit, or advance terms with established importers, because Yemeni banking and foreign exchange are constrained and split between authorities. We structure terms to protect both sides and treat continuity of supply over multiple tranches as the goal rather than maximising a single consignment.
What products does Yemen actually import from India?
Essential medicines above all: anti-infectives including antimalarials and outbreak-response lines, antibiotics, oral rehydration and nutrition products, maternal and child health lines and vaccines, and a growing block of non-communicable-disease basics such as insulin and cardiovascular and respiratory essentials. These WHO Essential Medicines List categories are where Indian WHO-GMP and WHO-prequalified supply is strongest and where donor procurement concentrates. M Care builds its Yemen portfolio around these rather than premium specialty lines that do not match how the country buys.
WHO-PQ essential medicines routed through donor, agency, and importer channels
WHO-PQ for UN tenders
Prequalified essential medicines and vaccines for UNICEF, WHO, and Global Fund-funded procurement, where WHO prequalification is the gating credential rather than a nice-to-have.
Licensed-importer and agency routing
Supply documented to the SBDMA-registered importer or the procuring agency that holds the correct registration for the destination zone, never bypassing local licensing.
Conflict-aware logistics
Aden and Hodeidah routing with UNVIM clearance, conservative payment instruments, and continuity of supply over multiple tranches treated as the deliverable.
Top categories we ship to Yemen
Anti-infectives
Antimalarials, antibiotics, and outbreak-response anti-infectives with oral rehydration and nutrition lines, the centre of donor-funded essential-medicines demand.
Vaccines
Routine and campaign vaccines for UNICEF and WHO programmes, WHO-prequalified where the line carries it, shipped under a validated cold-chain.
Antivirals
Essential antivirals for hospital and programme use, supplied from WHO-GMP partner sites with donor-format documentation.
Diabetes & endocrine
Insulin and endocrine essentials as the health system tries to maintain chronic care through the crisis, cold-chain handled conservatively.
Cardiovascular
Cardiovascular and hypertension essentials, the growing non-communicable-disease block in donor and hospital ordering.
General & OTC
Analgesics, antacids, oral rehydration salts, and basic family-pharmacy lines for importer and programme supply.
Services Yemeni buyers and agencies commonly bundle
NGO and donor procurement
Donor and NGO procurement support aligned to the Global Fund QA Policy, WHO-PQ, and ERP routes for UN-agency and humanitarian tenders.
WHO-GMP compliance
WHO-GMP and WHO-PQ evidence that underwrites a UN-agency tender bid or an SBDMA import licence in a market this scrutinised.
Cold-chain validated supply
Validated 2 to 8°C lanes for vaccines and temperature-sensitive lines into Aden, planned against constrained power and infrastructure.
Supplying Yemen through donors, agencies, or importers? Let us scope it.
Tell us the molecule or essential-medicines block, the destination zone, and whether it is donor, agency, or importer procurement, and we will confirm WHO-GMP and WHO-PQ options, the documentation route, and a realistic clearance and continuity plan. A named person on the Mumbai desk replies inside one working day, candid about what Yemen will and will not allow.